Heelan RT - Search Results

1

Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.

O'Connell JP, Kris MG, Gralla RJ, Groshen S, Trust A, Fiore JJ, Kelsen DP, Heelan RT, Golbey RB. O'Connell JP, et al. Among authors: heelan rt. J Clin Oncol. 1986 Nov;4(11):1604-14. doi: 10.1200/JCO.1986.4.11.1604. J Clin Oncol. 1986. PMID: 3021920

2

Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinoma.

Kelsen DP, Heelan R, Coonley C, Bains M, Martini N, Hilaris B, Golbey RB. Kelsen DP, et al. Am J Clin Oncol. 1983 Oct;6(5):539-46. Am J Clin Oncol. 1983. PMID: 6193704

3

Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy.

Miller VA, Rigas JR, Pisters KM, Grant SC, Pfister DG, Heelan RT, Kris MG. Miller VA, et al. Among authors: heelan rt. Am J Clin Oncol. 1995 Aug;18(4):303-6. doi: 10.1097/00000421-199508000-00007. Am J Clin Oncol. 1995. PMID: 7625371 Clinical Trial.

4

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.

Francis PA, Rigas JR, Kris MG, Pisters KM, Orazem JP, Woolley KJ, Heelan RT. Francis PA, et al. Among authors: heelan rt. J Clin Oncol. 1994 Jun;12(6):1232-7. doi: 10.1200/JCO.1994.12.6.1232. J Clin Oncol. 1994. PMID: 7911159 Clinical Trial.

5

Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials.

Pisters KM, Kris MG, Gralla RJ, Zaman MB, Heelan RT, Martini N. Pisters KM, et al. Among authors: heelan rt. J Clin Oncol. 1993 Sep;11(9):1757-62. doi: 10.1200/JCO.1993.11.9.1757. J Clin Oncol. 1993. PMID: 8394881

6

Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer.

Miller VA, Krug LM, Ng KK, Pizzo B, Perez W, Heelan RT, Kris MG. Miller VA, et al. Among authors: heelan rt. J Clin Oncol. 2000 Mar;18(6):1346-50. doi: 10.1200/JCO.2000.18.6.1346. J Clin Oncol. 2000. PMID: 10715307 Clinical Trial.

7

Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer.

Berger MZ, Kris MG, Gralla RJ, Marks LD, Potanovich LM, Dimaggio JJ, Heelan RT. Berger MZ, et al. Among authors: heelan rt. Am J Clin Oncol. 1991 Apr;14(2):124-6. doi: 10.1097/00000421-199104000-00006. Am J Clin Oncol. 1991. PMID: 1851387

8

Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung cancer.

Kris MG, D'Acquisto RW, Gralla RJ, Burke MT, Marks LD, Fanucchi MP, Heelan RT. Kris MG, et al. Among authors: heelan rt. Am J Clin Oncol. 1989 Feb;12(1):24-6. doi: 10.1097/00000421-198902000-00006. Am J Clin Oncol. 1989. PMID: 2536213

9

Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer.

Shum KY, Kris MG, Gralla RJ, Burke MT, Marks LD, Heelan RT. Shum KY, et al. Among authors: heelan rt. J Clin Oncol. 1988 Mar;6(3):446-50. doi: 10.1200/JCO.1988.6.3.446. J Clin Oncol. 1988. PMID: 2832548

10

Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer.

Kris MG, Gralla RJ, Wertheim MS, Kelsen DP, O'Connell JP, Burke MT, Fiore JJ, Cibas IR, Heelan RT. Kris MG, et al. Among authors: heelan rt. Cancer Treat Rep. 1986 Sep;70(9):1091-6. Cancer Treat Rep. 1986. PMID: 3527408 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters